Geneva: The World Health Organization Officer (WHO) said on Friday they hoped to hold a meeting immediately to establish guidelines about the use of Covid-19 antivirus pills, said they offered “very interesting” new prospects for clinical care.
England became the first country to approve one of the potential pills to change the game earlier this month.
Janet Diaz, high-ranking officials for clinical care response, said that the guidelines for meeting group meetings would consider Covid Pill questions in the meeting that will come in three weeks.
Another official Mike Ryan said the initial findings in the pill were “very, very welcomed”, adding that “careful process” is not needed before therapy must be broader expanded therapy.
“Obviously, having a second row approach to be able to treat those infected is very interesting and able to save lives that way is very interesting,” he said.
Last week Pfizer Inc.
(PFE.N) said the experimental antivirus pill was to treat Covid-19 Cut of 89% of inpatient opportunities or death for adults with the risk of severe illness.
In the same briefing, who was the main legal officer Steven Solomon said that talking about the international agreement to increase the readiness of advanced pandemics advancing from a large body meeting later this month.
“There is a good reason to believe them (which members) will achieve a successful conclusion,” he said.
The discussion also advanced on the list of potential emergency use for Russian Sputnik Vacine V Covid, said Mariangela Simao, added that further inspections were needed.
“The process moves again which is good news,” he said.
Who will set a guide to the Covid-19 antiviral pill soon
